Table 1.
Effects of fructose supplementation on bodyweight, fasting glycemia, theoretical creatinine clearance and plasma ASAT, ALAT, albumin and lipid levels.
Fig 1.
Effects of fructose supplementation on oral glucose tolerance test and its corresponding insulin level at age 9 and 13 weeks.
(1 A and B) Glycemia (mg/dL) is represented as a function of the time (min); at age 9 weeks, n = 8 for both C and FF, at age 13 weeks n = 7 for C rats and n = 8 for FF rats. (1 C and D) Insulin levels (ng/mL) are represented as a function of the time (min); at age 9 weeks, n = 6 for both C and FF, at age 13 weeks n = 7 for C rats and n = 7 for FF rats. FF: fructose supplemented; C: control. Statistical values: *<0.05, **<0.01, ***<0.001.
Fig 2.
Effects of fructose supplementation on Insulin Sensitivity Indices for glycemia (ISI-gly) and Homeostasis Model Assessment for Insulin Resistance (HOMA-IR).
(2A) ISI-gly was calculated at both 9 and 13 weeks. (2B) HOMA-IR was calculated at both 9 and 13 weeks. FF: fructose supplemented; C: control. For both indicator: at age 9 weeks n = 6 for both C and FF, at age 13 weeks n = 7 for C rats and n = 7 for FF rats. Statistical values: *<0.05, **<0.01, ***<0.001.
Fig 3.
Effects of fructose supplementation on systolic blood pressure and heart volume.
(3A) Systolic blood pressure was measure at age 8 weeks (n = 8 for both FF and C). (3B) Heart volume was measured at age 9 and 15 weeks; at age 9 weeks n = 8 for both C and FF rats, at age 15 weeks n = 7 for both groups. FF: fructose supplemented; C: control. Statistical values: *<0.05, **<0.01, ***<0.001.
Table 2.
Effects of fructose supplementation on GPx, CAT and SOD activities in both left ventricle (LV) and gastrocnemius.
(n = 8 in all conditions).